Antepartum Summary
0.0.1-current - ci-build
Antepartum Summary, published by IHE Patient Care Coordination Committee. This is not an authorized publication; it is the continuous build for version 0.0.1-current). This version is based on the current content of https://github.com/IHE/PCC.APS/ and changes regularly. See the Directory of published versions
Official URL: https://profiles.ihe.net/PCC/APS/ValueSet/Antepartum.Laboratory.VS | Version: 0.0.1-current | |||
Draft as of 2023-10-24 | Computable Name: Antepartum_Laboratory_VS |
TBD
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://loinc.org
Code | Display |
890-4 | Ab Screen |
883-9 | ABO Group |
10331-7 | Rh |
5196-1 | HBV surface Ag (EIA) |
5195-3 | HBV surface Ag |
5197-9 | HBV surface Ag (RIA) |
7905-3 | HBV surface Ag (Neut) |
718-7 | Hgb |
4544-3 | Hct (Automated count) |
30350-3 | Hgb |
13514-5 | Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative |
21440-3 | HPV I/H Risk DNA Cervix (Probe) |
21441-1 | HPV Low Risk DNA Cervix (Probe) |
10524-7 | Cytology Cervix |
18500-9 | Thin Prep Cervix |
19765-7 | Cytology Cervix/Vaginal (Nominal) |
19766-5 | Cytology Cervix/Vaginal (Narrative) |
5334-8 | RUBV Ab IgG (EIA) |
20458-6 | RUBV Ab IgG |
40667-8 | RUBV Ab IgG (EIA) |
8014-3 | RUBV Ab IgG |
1647-7 | Purified protein derivative skin test |
6347-9 | Chlamydia Ag |
14510-2 | Chlamydia trachomatis Ag (Vaginal) |
14474-1 | Chlamydia trachomatis Ag (Urine) |
6349-5 | Chlamydia trachomatis (Unspecified specimen) |
691-6 | Neisseria Gonorrhoeae (genital specimen) |
9568-7 | Neisseria Gonorrhoeaea Ab |
45067-6 | Chlamydia Trachomatis Neisseria Gonorrhoeae (Cervix) |
45074-2 | Chlamydia Trachomatis Neisseria Gonorrhoeae (Urine) |
35096-7 | OB Ultrasound Panel |
30525-0 | Age |
29463-7 | Body Weight |
18185-9 | Gestational Age |
20450-3 | Alpha-1-Fetoprotein |
48803-1 | Neural Tube Defect Risk |
33774-1 | Karotype |
33773-3 | Karyotype (Amino Fluid) |
41273-4 | Alpha-1-Fetoprotein, Amniotic Fluid Semi-Quantitative |
1832-5 | Alpha-1-Fetoprotein [Multiple of the median] in Amniotic Fluid |
29595-6 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic Fluid |
1557-8 | Fasting Blood Glucose-Venous |
14770-2 | Fasting Blood Glucose-Capillary |
1507-3 | Glucose 1HR post 75 g glucose |
14995-5 | Glucose 2HR post 75 g glucose |
20437-0 | Glucose 3HR post 75 g glucose |
31147-2 | Reagin Ab |
20508-8 | Reagin Ab by RPR |
5292-8 | Reagin Ab by VDRL |
48683-7 | Beta Strep Group B (PCR) |
11267-2 | Strep Group B |
21198-7 | Beta HCG |
15410-4 | Varicella zoster virus Ab.IgG (EIA) |
17763-4 | Varicella zoster virus Ab.IgG (IF) |
20465-1 | Choriogonadotropin/Choriogonatotropin, Control Serum Quantitative |
20466-9 | Estriol/Estriol, Control Serum Quantitative |
20406-5 | Glucose |
20505-4 | Bilirubin |
5797-6 | Ketones |
5811-5 | Specific Gravity |
5803-2 | pH |
5804-0 | Protein |
20405-7 | Urobilinogen |
20407-3 | Nitrite |
5794-3 | Hemoglobin |
5799-2 | Leukocyte esterase |
5767-9 | Appearance |
5778-6 | Color |
9842-6 | Casts |
5787-7 | Epithelial cells |
13945-1 | Erythrocytes |
5769-5 | Bacteria |
49588-7 | First trimester maternal screen with nuchal translucency [interpretation] Narrative |
11580-8 | Thyrotropin (3rd generation) |
3016-3 | TSH |
5385-0 | Thyrotropin Receptor Ab |
27975-2 | TSH (serum) |
3051-0 | T3 Free |
3052-8 | T3 Reverse |
3054-4 | T3 True |
3050-2 | T3 Resin Uptake |
This value set contains 81 concepts
Expansion based on:
Code | System | Display |
890-4 | http://loinc.org | Ab Screen |
883-9 | http://loinc.org | ABO Group |
10331-7 | http://loinc.org | Rh |
5196-1 | http://loinc.org | HBV surface Ag (EIA) |
5195-3 | http://loinc.org | HBV surface Ag |
5197-9 | http://loinc.org | HBV surface Ag (RIA) |
7905-3 | http://loinc.org | HBV surface Ag (Neut) |
718-7 | http://loinc.org | Hgb |
4544-3 | http://loinc.org | Hct (Automated count) |
30350-3 | http://loinc.org | Hgb |
13514-5 | http://loinc.org | Hemoglobin pattern [interpretation] in Blood by Electrophoresis Narrative |
21440-3 | http://loinc.org | HPV I/H Risk DNA Cervix (Probe) |
21441-1 | http://loinc.org | HPV Low Risk DNA Cervix (Probe) |
10524-7 | http://loinc.org | Cytology Cervix |
18500-9 | http://loinc.org | Thin Prep Cervix |
19765-7 | http://loinc.org | Cytology Cervix/Vaginal (Nominal) |
19766-5 | http://loinc.org | Cytology Cervix/Vaginal (Narrative) |
5334-8 | http://loinc.org | RUBV Ab IgG (EIA) |
20458-6 | http://loinc.org | RUBV Ab IgG |
40667-8 | http://loinc.org | RUBV Ab IgG (EIA) |
8014-3 | http://loinc.org | RUBV Ab IgG |
1647-7 | http://loinc.org | Purified protein derivative skin test |
6347-9 | http://loinc.org | Chlamydia Ag |
14510-2 | http://loinc.org | Chlamydia trachomatis Ag (Vaginal) |
14474-1 | http://loinc.org | Chlamydia trachomatis Ag (Urine) |
6349-5 | http://loinc.org | Chlamydia trachomatis (Unspecified specimen) |
691-6 | http://loinc.org | Neisseria Gonorrhoeae (genital specimen) |
9568-7 | http://loinc.org | Neisseria Gonorrhoeaea Ab |
45067-6 | http://loinc.org | Chlamydia Trachomatis Neisseria Gonorrhoeae (Cervix) |
45074-2 | http://loinc.org | Chlamydia Trachomatis Neisseria Gonorrhoeae (Urine) |
35096-7 | http://loinc.org | OB Ultrasound Panel |
30525-0 | http://loinc.org | Age |
29463-7 | http://loinc.org | Body Weight |
18185-9 | http://loinc.org | Gestational Age |
20450-3 | http://loinc.org | Alpha-1-Fetoprotein |
48803-1 | http://loinc.org | Neural Tube Defect Risk |
33774-1 | http://loinc.org | Karotype |
33773-3 | http://loinc.org | Karyotype (Amino Fluid) |
41273-4 | http://loinc.org | Alpha-1-Fetoprotein, Amniotic Fluid Semi-Quantitative |
1832-5 | http://loinc.org | Alpha-1-Fetoprotein [Multiple of the median] in Amniotic Fluid |
29595-6 | http://loinc.org | Alpha-1-Fetoprotein [Mass/volume] in Amniotic Fluid |
1557-8 | http://loinc.org | Fasting Blood Glucose-Venous |
14770-2 | http://loinc.org | Fasting Blood Glucose-Capillary |
1507-3 | http://loinc.org | Glucose 1HR post 75 g glucose |
14995-5 | http://loinc.org | Glucose 2HR post 75 g glucose |
20437-0 | http://loinc.org | Glucose 3HR post 75 g glucose |
31147-2 | http://loinc.org | Reagin Ab |
20508-8 | http://loinc.org | Reagin Ab by RPR |
5292-8 | http://loinc.org | Reagin Ab by VDRL |
48683-7 | http://loinc.org | Beta Strep Group B (PCR) |
11267-2 | http://loinc.org | Strep Group B |
21198-7 | http://loinc.org | Beta HCG |
15410-4 | http://loinc.org | Varicella zoster virus Ab.IgG (EIA) |
17763-4 | http://loinc.org | Varicella zoster virus Ab.IgG (IF) |
20465-1 | http://loinc.org | Choriogonadotropin/Choriogonatotropin, Control Serum Quantitative |
20466-9 | http://loinc.org | Estriol/Estriol, Control Serum Quantitative |
20406-5 | http://loinc.org | Glucose |
20505-4 | http://loinc.org | Bilirubin |
5797-6 | http://loinc.org | Ketones |
5811-5 | http://loinc.org | Specific Gravity |
5803-2 | http://loinc.org | pH |
5804-0 | http://loinc.org | Protein |
20405-7 | http://loinc.org | Urobilinogen |
20407-3 | http://loinc.org | Nitrite |
5794-3 | http://loinc.org | Hemoglobin |
5799-2 | http://loinc.org | Leukocyte esterase |
5767-9 | http://loinc.org | Appearance |
5778-6 | http://loinc.org | Color |
9842-6 | http://loinc.org | Casts |
5787-7 | http://loinc.org | Epithelial cells |
13945-1 | http://loinc.org | Erythrocytes |
5769-5 | http://loinc.org | Bacteria |
49588-7 | http://loinc.org | First trimester maternal screen with nuchal translucency [interpretation] Narrative |
11580-8 | http://loinc.org | Thyrotropin (3rd generation) |
3016-3 | http://loinc.org | TSH |
5385-0 | http://loinc.org | Thyrotropin Receptor Ab |
27975-2 | http://loinc.org | TSH (serum) |
3051-0 | http://loinc.org | T3 Free |
3052-8 | http://loinc.org | T3 Reverse |
3054-4 | http://loinc.org | T3 True |
3050-2 | http://loinc.org | T3 Resin Uptake |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |